Peddareddigari, Vijay GR
Hospital of the University of Pennsylvania · Janssen Research & Development (United States)
2 papers on CoChat
Most cited papers
- Verified
Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial.
Infante, J. R., Fecher, L. A., Falchook, G. S., Nallapareddy, S., Gordon, M. S., Becerra, C., DeMarini, D. J., Cox, D. S., Xu, Y., Morris, S. R., et al. (2012) · The Lancet Oncology
Melanoma and MAPK PathwaysProtein Tyrosine Phosphatases
Cited by 552
- Verified
EGFR Fusions as Novel Therapeutic Targets in Lung Cancer
Konduri, K., Gallant, J.-N., Chae, Y. K., Giles, F. J., Gitlitz, B. J., Gowen, K., Ichihara, E., Owonikoko, T. K., Peddareddigari, V., Ramalingam, S. S., et al. (2016) · Cancer Discovery
Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research
Cited by 144
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free